-
How Price Discrimination is Good for Global Health (Part 2): Patricia Danzon describes how the concept, despite its theoretical upside, ‘is not working very well’ in practice
?In Part 1 of her interview with NBHC, professor Patricia Danzon of The Wharton School, University of Pennsylvania laid out some of the advantages of differential pricing in pharmaceuticals. In Part 2, she describes how the concept works in practice, including the key role of politics in its implementation.
- Categories
- Education, Health Care
-
Glaxo’s Ebola Vaccine and the Rise of Tropical-Disease R&D
Financial arguments may finally be leading Big Pharma to increase its minuscule investment in research and development of new drugs for tropical diseases.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
FDA rushes J&J, NewLink Genetics Ebola vaccines to clinical trials
Another Big Pharma player is joining the hustle toward an Ebola vaccine as the death toll surpasses 1,900 victims, eclipsing the total number of people who died from the disease in all previous outbreaks combined.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Canada Ebola vaccine shipment to Africa stymied by logistics
Canada's experimental Ebola vaccine was stuck in the government lab that developed it as officials puzzled over how to safely transport it, three weeks after it was offered to Africa to fight the deadly epidemic.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Final trial confirms efficacy of Sanofi’s dengue vaccine
French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 percent in a large final clinical trial. Sanofi has invested more than 1.3 billion euros ($1.7 billion) in the project, undertaking two decades of research on the world's fastest-growing tropical disease.
- Categories
- Health Care
- Tags
- vaccines
-
Ebola: Can Global Health Be Sustainably Promoted Without A Framework Convention for Global Health?
Few events remind us more of humanity’s shared health vulnerability than the outbreak of an untreatable, highly lethal disease that is resisting efforts to contain it, spreading from community to community, and across borders from country to country – like the current Ebola outbreak in West Africa.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Global health officials warn that window for bringing Ebola under control is closing fast
Leading international health officials said Tuesday that the Ebola epidemic in West Africa is accelerating and the window for getting it under control is closing.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Ebola outbreak could infect 20,000 people, WHO says
The Ebola epidemic in West Africa could infect over 20,000 people and spread to more countries, the U.N. health agency said on Thursday, warning that an international effort costing almost half a billion dollars is needed to overcome the outbreak.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.